Fitbit Launches Heart Study to Validate its Wearable Technology for Identifying Atrial Fibrillation

Fitbit Launches Heart Study to Validate its Wearable Technology for Identifying Atrial Fibrillation

Shots:

  • Fitbit launched the Fitbit Heart Study, which focuses to validate the use of its wearables to detect AFib. The virtual study is open to Fitbit users aged 22yrs. + with a current Fitbit device and will enroll hundreds of thousands of people with its results supporting the Company’s regulatory submissions globally
  • Fitbit’s devices use photoplethysmography technology to measure blood flow rate from a user’s wrist and those measurements can be used to identify heart rhythm, which Fitbit’s algorithm will analyze for irregularities in the study
  • Participants who are notified with an irregular heart rhythm will get a free virtual appointment with a doctor and mailed with an ECG patch to confirm the notification. Additionally, With the launch of the heart study, Fitbit is giving competition to Apple which received FDA clearance in 2018 for its ECG feature and launched a study with J&J to explore whether its wearables can detect Afib

Click here to­ read full press release/ article | Ref: Business wire | Image: Fitbit